✦ LIBER ✦

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)

✍ Scribed by Fumoleau, Pierre; Koch, Kevin M.; Brain, Etienne; Lokiec, François; Rezai, Keyvan; Awada, Ahmad; Hayward, Larry; Werutsky, Gustavo; Bogaerts, Jan; Marréaud, Sandrine; Cardoso, Fatima

Book ID: 127382780
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 727 KB
Volume: 23
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2014.07.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EORTC 10968; Phase I study of CaelyxTM a

EORTC 10968; Phase I study of CaelyxTM at a six week interval in patients with metastatic breast cancer

✍ A. Hamilton; R. Coleman; L. Mauriac; A. Awada; M. Piccart; A. Van Vreckem; P. Br 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A phase II study of lapatinib and bevaci

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer

✍ Hope S. Rugo, A. Jo Chien, Sandra X. Franco, Alison T. Stopeck, Alexa Glencer, S 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 271 KB

A Phase I Study of UFT-Oral Vinorelbine

A Phase I Study of UFT-Oral Vinorelbine in Metastatic Breast Cancer

✍ Ferrero, J.M.; Largillier, R.; Michel, C.; Amiot, V.; Milano, G.; Hébert, C.; Ma 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 211 KB

Phase I/II study of paclitaxel and vinor

Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer

✍ Anna Tortoriello; Gaetano Facchini; Francesco Caponigro; Michele Santangelo; Gia 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 32 KB

A Phase I and pharmacokinetic study of h

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

✍ Edward F. McClay; Mary-Eileen T. McClay; Jeffery A. Jones; Paul J. Winski; Rando 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

by 40 mg to the MTD in groups of 3 patients. DDP (80 mg/m 2 ) was begun on Day ogy/Oncology, Hollings Cancer Center, Medical 2 and repeated weekly for a total of 3 weeks. During Week 4, the patients were University of South Carolina, Charleston, South not treated with DDP but instead evaluated for r

A Phase I/II Study of Lapatinib Plus Car

A Phase I/II Study of Lapatinib Plus Carboplatin and Paclitaxel in Relapsed Ovarian and Breast Cancer

✍ Saul E. Rivkin; Carolyn Muller; Judith A. Malmgren; James Moon; Desiree Iriarte; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB